Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05447923
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Educational Intervention — OTHERUndergo education for colorectal cancer screening
- Fecal Immunochemical Test — OTHERUndergo FIT testing
- Patient Navigation — BEHAVIORALUndergo patient navigation for positive FIT results
- Questionnaire Administration — OTHERComplete questionnaire about colorectal cancer screening and healthcare
Study Details
This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.
Key Dates
- Start date
- May 22, 2022
- Status verified
- Apr 2026
- Primary completion
- Jun 1, 2030
- Completion
- Jun 1, 2030
Study Design
- Enrollment
- 450 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Experimental: Screening (FIT, education, questionnaire, patient navigation)Participants receive free FIT tests in conjunction with education on colorectal cancer screening. Participants undergo self-collect FIT and mail the sample to Mayo Clinic Lab for processing. Participants also complete a questionnaire about colorectal cancer screening and healthcare. Participants receive FIT test results through Mayo Clinic nursing support and participants with a positive test are followed up by a patient navigator to discuss next steps and consultation with a gastroenterologist to review their results.
Primary Outcome Measure
Colorectal cancer disparities seen in people of color and minority populations [ Time Frame: Up to study completion, up to 30 days ]
Central Contacts
- Yahaira J. Parker480-574-3171
- Clinical Trials Referral Office855-776-0015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | Arizona | 85259 | Juliana M. Kling, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
Related Studies
- Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome PatientsRecruiting · Mayo Clinic · Scottsdale, Arizona
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesPHASE1/PHASE2 · Recruiting · Institut de Recherches Internationales Servier · Gilbert, Arizona
- A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPHASE1 · Recruiting · AstraZeneca · Gilbert, Arizona
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsRecruiting · Wake Forest University Health Sciences · Fairbanks, Alaska